Description:

NSABP PROTOCOL B-35 Treatment Form for Tamoxifen/Anastrozole NCT00053898 Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A051E957-2260-0392-E034-080020C9C0E0

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A051E957-2260-0392-E034-080020C9C0E0

Keywords:
Versions (3) ▾
  1. 8/26/12
  2. 5/22/15
  3. 6/3/15
Uploaded on:

June 3, 2015

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

NSABP PROTOCOL B-35 Treatment Form for Tamoxifen/Anastrozole NCT00053898

Form T (04-30-2002) Submit this form when Tamoxifen/Anastrozole therapy has ended or if the patient did not begin Tamoxifen/Anastrozole.

Header Module
Are data amended? (If Yes, circle the amended items in red.)
Summary Of Tamoxifen/anastrozole Administration
Reason for end of treatment
Reason Treatment Ended (Select the reason that best explains why treatment has ended, or why the patient did not begin treatment.)

Similar models